Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes
- PMID: 17488515
- PMCID: PMC1877800
- DOI: 10.1186/1743-422X-4-41
Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes
Abstract
Background: La Crosse virus (LACV), family Bunyaviridae, is a mosquito-borne virus recognized as a major cause of pediatric encephalitis in North America with 70-130 symptomatic cases each year. The virus was first identified as a human pathogen in 1960 after its isolation from a 4 year-old girl who suffered encephalitis and died in La Crosse, Wisconsin. The majority of LACV infections are mild and never reported, however, serologic studies estimate infection rates of 10-30/100,000 in endemic areas.
Results: In the present study, sequence analysis of the complete LACV genomes of low-passage LACV/human/1960, LACV/mosquito/1978, and LACV/human/1978 strains and of biologically cloned derivatives of each strain, indicates that circulating LACVs are genetically stable over time and geographic distance with 99.6-100%, 98.9-100%, 97.8-99.6%, and 99.2-99.7% amino acid identity for N, NsS, M polyprotein, and L proteins respectively. We identified 5 amino acid differences in the RNA polymerase and 4 nucleotide differences in the non-coding region of the L segment specific to the human virus isolates, which may result in altered disease outcomes.
Conclusion: All three wild type viruses had similar in vitro growth kinetics and phenotypes in mosquito C6/36 and Vero cells, and similar levels of neurovirulence and neuroinvasiveness in Swiss Webster mice. The biologically cloned derivative of LACV/human/1960 was significantly less neuroinvasive than its uncloned parent and differed in sequence at one amino acid position in the GN glycoprotein, identifying this residue as an attenuating mutation.
Figures



Similar articles
-
La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.Virol J. 2008 Feb 11;5:25. doi: 10.1186/1743-422X-5-25. Virol J. 2008. PMID: 18267012 Free PMC article.
-
Tahyna virus genetics, infectivity, and immunogenicity in mice and monkeys.Virol J. 2011 Mar 24;8:135. doi: 10.1186/1743-422X-8-135. Virol J. 2011. PMID: 21435229 Free PMC article.
-
A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.J Virol. 2012 Jan;86(1):420-6. doi: 10.1128/JVI.02327-10. Epub 2011 Oct 19. J Virol. 2012. PMID: 22013033 Free PMC article.
-
La Crosse Virus: A Comprehensive Review of Its Emerging Public Health Importance.Viral Immunol. 2025 May;38(4):137-147. doi: 10.1089/vim.2024.0088. Epub 2025 Apr 24. Viral Immunol. 2025. PMID: 40274395 Review.
-
Current Status of La Crosse Virus in North America and Potential for Future Spread.Am J Trop Med Hyg. 2024 Mar 26;110(5):850-855. doi: 10.4269/ajtmh.23-0160. Print 2024 May 1. Am J Trop Med Hyg. 2024. PMID: 38531108 Free PMC article. Review.
Cited by
-
The transmission ecology of Tahyna orthobunyavirus in Austria as revealed by longitudinal mosquito sampling and blood meal analysis in floodplain habitats.Parasit Vectors. 2021 Oct 30;14(1):561. doi: 10.1186/s13071-021-05061-1. Parasit Vectors. 2021. PMID: 34717742 Free PMC article.
-
Purifying selection decreases the potential for Bangui orthobunyavirus outbreaks in humans.Virus Evol. 2023 Mar 8;9(1):vead018. doi: 10.1093/ve/vead018. eCollection 2023. Virus Evol. 2023. PMID: 37025159 Free PMC article.
-
La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.Virol J. 2008 Feb 11;5:25. doi: 10.1186/1743-422X-5-25. Virol J. 2008. PMID: 18267012 Free PMC article.
-
Innate immune response to La Crosse virus infection.J Neurovirol. 2014 Apr;20(2):150-6. doi: 10.1007/s13365-013-0186-6. Epub 2013 Jul 12. J Neurovirol. 2014. PMID: 23846288 Review.
-
La Crosse Virus Shows Strain-Specific Differences in Pathogenesis.Pathogens. 2021 Mar 29;10(4):400. doi: 10.3390/pathogens10040400. Pathogens. 2021. PMID: 33805389 Free PMC article.
References
-
- Rust RS, Thompson WH, Matthews CG, Beaty BJ, Chun RW. La Crosse and other forms of California encephalitis. J Child Neurol. 1999;14:1–14. - PubMed
-
- Thompson WH, Gundersen CB. La Crosse encephalitis: occurrence of disease and control in a suburban area. Prog Clin Biol Res. 1983;123:225–236. - PubMed
-
- Thompson WH, Kalfayan B, Anslow RO. Isolation of California Encephalitis Group Virus From a Fatal Human Illness. American Journal Of Epidemiology. 1965;81:245–253. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases